MarketPeel
Insider Trading Intelligence
YO

Yat Sun Or

ENTA
CHIEF SCIENTIFIC OFFICER · ENANTA PHARMACEUTICALS INC · CIK 0001571212
FILING MIX · LIFETIME51%/49%
BUYS
25
SELLS
24
TOTAL VALUE
$2.03M
COMPANIES
1
ACTIVE SINCE
Dec 2019
HOLDINGS NOW
378,267
AVG SELL PX
$33.61
TRADE KIND
SHOWING 49 / 49
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Yat Sun Or, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-6.92%+0.55%-7.47%-11.94%
14d3+66.67%-4.55%+2.08%-6.63%-13.02%
30d3+100.00%-13.53%+4.34%-17.87%-24.29%
60d3+100.00%-30.27%+4.52%-34.79%-48.38%
90d3+100.00%-31.47%+8.19%-39.66%-56.86%
180d3+100.00%-53.86%+16.07%-88.05%-88.05%
1y3(1 pending)+100.00%-68.86%+34.29%-103.16%-103.16%
2y3(1 pending)+100.00%-85.06%+48.66%-133.72%-133.72%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ENTA · 378,267 shares · as of Feb 12, 2026
097,157194,314291,470388,6272020202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 25 buys / 24 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Chief Scientific Officer
3,413$14.25$48.6K374,854Feb 12, 2026Feb 13, 2026View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,650373,042Feb 12, 2026Feb 13, 2026View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,225378,267Feb 12, 2026Feb 13, 2026View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Chief Scientific Officer
2,390$14.23$34.0K371,392Dec 5, 2025Dec 5, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Chief Scientific Officer
753$14.12$10.6K373,782Dec 1, 2025Dec 3, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
110,000110,000Nov 25, 2025Nov 26, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Chief Scientific Officer
4,324$5.59$24.2K374,535Feb 12, 2025Feb 14, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,750378,859Feb 12, 2025Feb 14, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,591$8.06$20.9K369,109Dec 6, 2024Dec 10, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Chief Scientific Officer
1,595$8.60$13.7K371,700Dec 1, 2024Dec 3, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
87,00087,000Nov 27, 2024Nov 27, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,680374,375Feb 12, 2024Feb 14, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Chief Scientific Officer
1,080$12.41$13.4K373,295Feb 12, 2024Feb 14, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP, R&D & CSO
2,412$9.63$23.2K370,695Dec 5, 2023Dec 6, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP, R&D & CSO
1,595$9.49$15.1K373,107Dec 1, 2023Dec 5, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
86,00086,000Nov 22, 2023Nov 22, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
Sr. VP & CSO
13,925$14.00$194.9K388,627Mar 15, 2023Mar 17, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
13,9250Mar 15, 2023Mar 17, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
269$43.92$11.8K388,358Mar 15, 2023Mar 17, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
13,656$44.46$607.1K374,702Mar 15, 2023Mar 17, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
7,752$52.77$409.1K374,702Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,250369,437Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,017382,454Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
1,055$44.33$46.8K359,187Dec 1, 2022Dec 5, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
45,00045,000Nov 23, 2022Nov 28, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
21,000360,242Nov 23, 2022Nov 28, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
615337,776Feb 14, 2022Feb 15, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,419340,195Feb 14, 2022Feb 15, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
953$62.49$59.6K339,242Feb 14, 2022Feb 15, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
557$87.68$48.8K337,161Dec 1, 2021Dec 3, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
28,40028,400Nov 19, 2021Nov 23, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,800337,718Nov 19, 2021Nov 23, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
4,8720Jan 26, 2021Jan 28, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
Sr. VP & CSO
3,672$11.77$43.2K326,046Jan 26, 2021Jan 28, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
5,1490Jan 26, 2021Jan 28, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
Sr. VP & CSO
4,872$11.77$57.3K330,918Jan 26, 2021Jan 28, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
Sr. VP & CSO
5,149$14.18$73.0K322,374Jan 26, 2021Jan 28, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
3,6720Jan 26, 2021Jan 28, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
5,2500Dec 15, 2020Dec 16, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
Sr. VP & CSO
5,250318,765Dec 15, 2020Dec 16, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
1,540$42.52$65.5K317,225Dec 15, 2020Dec 16, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,600313,515Nov 20, 2020Nov 20, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,80030,800Nov 20, 2020Nov 20, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
1,089$52.76$57.5K305,915Feb 12, 2020Feb 14, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
487304,079Feb 12, 2020Feb 14, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,925307,004Feb 12, 2020Feb 14, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
2,331$63.88$148.9K303,592Dec 16, 2019Jan 6, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
Sr. VP & CSO
5,250305,923Dec 16, 2019Jan 6, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
Sr. VP & CSO
5,2505,250Dec 16, 2019Jan 6, 2020View →
Other insiders · ENTA
Loading peer insiders…
About this filer
CIK 0001571212
ROLE
Chief Scientific Officer
PRIMARY
ENTA
COMPANIES
1
ACTIVE SINCE
Dec 2019
MARKETPEEL · /INSIDER/0001571212DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback